Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Electronic Pill Helps Combat Obesity Eating Disorders

By HospiMedica International staff writers
Posted on 06 May 2015
A prototype electronic capsule delivers electrical stimulation to the muscles of the stomach wall, giving the patient a feeling of satiety and reducing their urge for food intake.

The MelCap system is comprised of three main parts; a remotely controlled capsule adapted for ingestion or placement into the gastrointestinal tract (GT); a remote control device or smartphone for controlling and sharing information with the capsule; and a magnetic coupling system for fixing the capsule within the GI tract of the patient. More...
The capsule, the size of a large pill, is first swallowed by the patient. Upon arrival into the stomach, it absorbs stomach fluids, increasing its size, enabling it to remain in place and operate continuously.

Once in place, the magnetic coupling system is used to position it in the specific spot selected within the stomach, be it near the lower esophagus sphincter (LES) or in proximity to the vagus nerve. The pill unfurls a mesh filled with inflated particles and the wireless device is then used to activate the pill. When it receives the signal, the pill delivers a series of electrical pulses to stimulate the lining of the stomach. Depending on the pill’s location, different effects can be achieved to tailor the therapy to individual patient needs.

These could include, for example, gastric electrical stimulation (GES), LES muscle simulation, or vagus nerve blocking. The capsule continues to deliver electrical stimulation for up to 21 days, continuously monitored and controlled remotely by the wireless device. When exhausted, some of the biologic components are absorbed, while the electronic components are expelled from the system. The MelCap system is a product of Melcap (Ramat Gan, Israel).

Related Links:
Melcap



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.